Role and potential clinical utility of ARID1A in gastrointestinal malignancy

Authors：Wang, Ruihua; Chen, Mei; Ye, Xiaojun; Poon, Karen^*

Source：Mutation Research - Reviews in Mutation Research, 2021, 787: 108360.

DOI：10.1016/j.mrrev.2020.108360

• ARID1A
• Gastrointestinal cancers
• Microsatellite instability
• Mismatch repair
• PI3K
• ATK signaling pathway
• Prognosis

ARID1A (AT-rich interactive domain 1A) is a newly discovered tumor suppressor gene, and its encoded product is an important component of the SWI/SNF chromatin remodeling complex. ARID1A plays an important role in cell proliferation, invasion and metastasis, apoptosis, cell cycle regulation, epithelial mesenchymal transition, and the regulation of other of biological behaviors. Recently, ARID1A mutations have been increasingly reported in esophageal adenocarcinoma, gastric cancer, colorectal cancer, hepatocellular carcinoma, cholangiocarcinoma, pancreatic cancer, and other malignant tumors of the digestive system. This article reviews the relationship between ARID1A mutation and the molecular mechanisms of carcinogenesis, including microsatellite instability and the PI3K/ATK signaling pathway, and relates these mechanisms to the prognostic assessment of digestive malignancy. Further, this review describes the potential for molecular pathologic epidemiology (MPE) to provide new insights into environment-tumor-host interactions.

• Institution
  南方医科大学